Fagron NV (LON:0HNZ)
21.30
+0.80 (3.90%)
At close: Dec 19, 2025
Fagron NV Market Cap
Fagron NV has a market cap or net worth of 1.37 billion as of December 22, 2025. Its market cap has increased by 23.74% in one year.
Market Cap
1.37B
Enterprise Value
1.65B
Revenue
787.55M
Ranking
n/a
PE Ratio
18.61
Stock Price
21.30
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 217.33M to 1.37B, an increase of 528.93%. That is a compound annual growth rate of 10.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.37B | 35.27% |
| Dec 31, 2024 | 1.01B | -4.00% |
| Dec 29, 2023 | 1.05B | 22.70% |
| Dec 30, 2022 | 857.92M | -5.27% |
| Dec 31, 2021 | 905.64M | -26.49% |
| Dec 31, 2020 | 1.23B | 4.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| HSBC Holdings | 200.10B |
| Shell | 154.83B |
| Unilever | 108.28B |
| Rio Tinto Group | 99.46B |
| Rolls-Royce Holdings | 97.94B |
| British American Tobacco p.l.c. | 92.05B |
| GSK plc | 73.11B |